| Valproic acid | Approved Investigational | AKR1C3 | 8644 |
upregulated | Valproic Acid results in increased expression of AKR1C3 mRNA | 10p15.1 | |
| Valproic acid | Approved Investigational | AKR1D1 | 6718 |
downregulated | Valproic Acid results in decreased expression of AKR1D1 mRNA | 7q33 | |
| Valproic acid | Approved Investigational | AKR1E2 | 83592 |
upregulated | Valproic Acid results in increased expression of AKR1E2 mRNA | 10p15.1 | |
| Valproic acid | Approved Investigational | AKT1 | 207 |
upregulated | Valproic Acid results in increased expression of AKT1 mRNA | 14q32.33 | |
| Valproic acid | Approved Investigational | AKT2 | 208 |
downregulated | Valproic Acid results in decreased expression of AKT2 mRNA | 19q13.2 | |
| Valproic acid | Approved Investigational | AKT3 | 10000 |
downregulated | Valproic Acid results in decreased expression of AKT3 mRNA | 1q43-q44 | |
| Valproic acid | Approved Investigational | ALAD | 210 |
upregulated | Valproic Acid results in increased expression of ALAD mRNA | 9q32 | |
| Valproic acid | Approved Investigational | ALB | 213 |
upregulated | Valproic Acid results in increased expression of ALB mRNA | 4q13.3 | |
| Valproic acid | Approved Investigational | ALCAM | 214 |
upregulated | Valproic Acid results in increased expression of ALCAM mRNA | 3q13.11 | |
| Valproic acid | Approved Investigational | ALDH1A1 | 216 |
upregulated | Valproic Acid results in increased expression of ALDH1A1 mRNA | 9q21.13 | |
| Valproic acid | Approved Investigational | ALDH1A2 | 8854 |
downregulated | Valproic Acid results in decreased expression of ALDH1A2 mRNA | 15q21.3 | |
| Valproic acid | Approved Investigational | ALDH1A3 | 220 |
upregulated | Valproic Acid results in increased expression of ALDH1A3 mRNA | 15q26.3 | |
| Valproic acid | Approved Investigational | ALDH1B1 | 219 |
upregulated | Valproic Acid results in increased expression of ALDH1B1 mRNA | 9p13.1 | |
| Valproic acid | Approved Investigational | ALDH1L2 | 160428 |
upregulated | Valproic Acid results in increased expression of ALDH1L2 mRNA | 12q23.3 | |
| Valproic acid | Approved Investigational | ALDH2 | 217 |
downregulated | Valproic Acid results in decreased expression of ALDH2 mRNA | 12q24.12 | |
| Valproic acid | Approved Investigational | ALDH3B2 | 222 |
upregulated | Valproic Acid results in increased expression of ALDH3B2 mRNA | 11q13.2 | |
| Valproic acid | Approved Investigational | ALDH5A1 | 7915 |
downregulated | Valproic Acid results in decreased expression of ALDH5A1 mRNA | 6p22.3 | |
| Valproic acid | Approved Investigational | ALDH6A1 | 4329 |
downregulated | Valproic Acid results in decreased expression of ALDH6A1 mRNA | 14q24.3 | |
| Valproic acid | Approved Investigational | ALDH7A1 | 501 |
downregulated | Valproic Acid results in decreased expression of ALDH7A1 mRNA | 5q23.2 | |
| Valproic acid | Approved Investigational | ALDH8A1 | 64577 |
upregulated | Valproic Acid results in increased expression of ALDH8A1 mRNA | 6q23.3 | |
| Valproic acid | Approved Investigational | ALDH9A1 | 223 |
upregulated | Valproic Acid results in increased expression of ALDH9A1 mRNA | 1q24.1 | |
| Valproic acid | Approved Investigational | ALDOA | 226 |
downregulated | Valproic Acid results in decreased expression of ALDOA mRNA | 16p11.2 | |
| Valproic acid | Approved Investigational | ALDOC | 230 |
downregulated | Valproic Acid results in decreased expression of ALDOC mRNA | 17q11.2 | |
| Valproic acid | Approved Investigational | ALG10 | 84920 |
upregulated | Valproic Acid results in increased expression of ALG10 mRNA | 12p11.1 | |
| Valproic acid | Approved Investigational | ALG10B | 144245 |
downregulated | Valproic Acid results in decreased expression of ALG10B mRNA | 12q12 | |